Close Menu

NEW YORK — Quotient Limited on Tuesday reported a 5 percent year-over-year increase in revenues for its fiscal fourth quarter on gains made by its Alba reagent business.

For the three-month period ended March 31, Quotient's revenues climbed to $8.7 million from $8.3 million the year before, bolstered by an 11 percent year-over-year rise in reagent revenues. The company's revenues in its Q4 2019 included a $450,000 milestone payment under a now-ended supply agreement with Ortho Clinical Diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.